Bringing Together the Top Minds Across Vector Engineering, Viral Vector Delivery Systems and Next-Generation Gene Transfer Technologies Further Cements Form Bio’s Position as a Leader in AI-Driven Cell and Gene Therapy
Read MoreThis additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read MoreLimulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population
Read MoreDropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ is designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.
Read MoreGoogle Cloud’s Powerful AI Models for Healthcare and Life Sciences Research Now Available as Point-and-Click Workflows via Form Bio's Bioinformatics Platform, Available on Google Cloud Marketplace
Read MoreFIECON, a leading health economics consultancy, in collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions, has embarked on a transformative journey together. By harnessing innovative AI technology, this collaboration aims to significantly streamline the Systematic Literature Review (SLR) and meta-analysis process.
Read MoreThe Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read More